David Matthew T

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 73% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
David Matthew T's trades of CorMedix Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US CorMedix Inc (CRMD)
Transaction date
Proposed sale
Price
309.50
Quantity 6,660
Value US$4,121,323
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
314.55
Quantity 91,283 -23.4%
Value US$133,721
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
286.09
Quantity 79,458 -39.0%
Value US$4,218,189
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
5.07
Quantity 1,000 +87.0%
Value US$5,070
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
4.07
Quantity 1,150 +inf%
Value US$4,680
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-03 2025-09-03
US CorMedix Inc (CRMD)
PrS Proposed sale
6,660
309.50
US$4,121,323 		6,660 309.50 US$4,121,323
2021-12-07 2021-12-06
US CorMedix Inc (CRMD)
B Purchase
91,283 -23.4%
314.55
US$133,721 		91,283 -23.4% 314.55 US$133,721
2021-12-07 2021-12-06
US CorMedix Inc (CRMD)
B Purchase
79,458 -39.0%
286.09
US$4,218,189 		79,458 -39.0% 286.09 US$4,218,189
2021-11-19 2021-11-17
US CorMedix Inc (CRMD)
B Purchase
1,000 +87.0%
5.07
US$5,070 		1,000 +87.0% 5.07 US$5,070
2020-09-08 2020-09-03
US CorMedix Inc (CRMD)
B Purchase
1,150 +inf%
4.07
US$4,680 		1,150 +inf% 4.07 US$4,680